CII
BSX icon

CR Intrinsic Investors’s Boston Scientific BSX Stock Holding History

CR Intrinsic Investors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,500,000
Closed -$33.8M – 33
2014
Q1 		$33.8M Buy
2,500,000
+2,000,000
+400% +$26.3M 1.27% 9
2013
Q4 		$6.01M Buy
+500,000
New +$5.91M 0.26% 139

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CR Intrinsic Investors's BSX Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Boston Scientific (BSX) in Q2 2014, closing a stake of 2,500,000 shares — an estimated $33.8M sold.

CR Intrinsic Investors first reported a position in BSX in Q4 2013 and held it in 2 quarters. The position peaked at $33.8M in Q1 2014. 457 funds tracked by Wall St. Rank hold BSX as of Q2 2014.

  • CR Intrinsic Investors reported no remaining Boston Scientific position as of Q2 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 2,500,000 Boston Scientific shares in Q2 2014, an estimated $33.8M.
  • CR Intrinsic Investors first reported a position in Boston Scientific in Q4 2013 and held it in 2 quarters.
  • CR Intrinsic Investors's Boston Scientific position peaked at $33.8M in Q1 2014.
  • 457 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.